Newsletter - April 2020
FEATURED CONTENT: COVID-19 and the Health Impact (and Pharma)
DHC Group leadership have been following the adoption of digital health since 1999 and witnessed a significant amount of change and disruption in the past two months. Covid-19 has acted as an accelerant and provided cover for ‘riskier’ transitions to digital. We have outlined a few observations for your consideration that we think will ‘stick’ once the pandemic has subsided. Look for a much further drill down on each from the DHC over the next few months.
ADDITIONAL INSIGHTS FROM DHC PARTNERS
DHC's Mark Bard Interviews Brian Fox, Senior Partner at McKinsey, on Navigating the Uneven Recovery
Via DHC →
DHC's Mark Bard interviewed Brian Fox, Senior Partner at McKinsey & Company on his perspective on the current climate for pharma around COVID-19. This conversation is summarized in the 8 minute video provided, as well as a link to a recent article by Brian on the same topic.
Watch Here →
Non-Personal Promotion in the Wake of a Wildly Changing Digital Landscape
Via DHC and Everyday Health Professional→
This conversation with Tony Dale, SVP Everyday Health Professional & CRO MedPage Today provides a publisher's perspective on the here, now and beyond. This piece examines whether we are at an HCP tipping point, the expansive nature of digital activity currently, to shift from personal to promotional, and whether this pivot a long-term new normal.
Read More →
Digital Tools at the Point of Care offer Practice Extensions During COVID-19 - DHC Roundtable
Via DHC →
Earlier this month, we hosted a virtual roundtable with POC experts in response to the impact of COVID-19 on the point of care. The theme of this discussion was digital tools at the point of care as a practice extension, especially in light of the current environment. There’s a perception that most physicians right now have closed their practices. The reality is more of a mixed bag. The video summary of the discussion is a 9 minute watch.
Read More and Watch Here →
Sermo Surveys over 1,000 Physicians on Current Sentiments
Via Sermo →
Using thoughtful questions provided by industry members, Sermo has created the COVID-19 HCP Sentiment Study Series. Over 1,000 physicians across the world have donated their time to answer our collective COVID-19 questions.
The Part 2 report covers:
• Impact on Med Tech and Pharma rep meetings
• Most useful support or information from manufacturers
• Most effective formats to receive info from industry
• Ways manufacturers can be most effective, and more.
Download Here →
Rise of Digital Non-Personal Promotion Created by COVID-19 - A DHC Roundtable
Via DHC →
DHC’s Co-Founder, Mark Bard, hosted a virtual roundtable on the rapid rise of digital delivery for non-personal promotion due to the very dynamic environment created by COVID-19. Roundtable participants included Mark Davis (SVP, Multichannel Delivery at HCB Health), Neil Keene (Pharma Marketer, Consultant, www.neilkeene.com), and Heath Morlok (Sr. Director, Market Value & Impact, Everyday Health Professional). The video summary is a 7 minute watch.
Read More and Watch Here →
Coming May 13 - Webinar Series from IQVIA Exploring New Normal
Via IQVIA →
While the industry cautiously continues to embrace digital engagement as a strategic channel, current circumstances surrounding COVID-19 may influence your decision to accelerate adoption. Topic focus includes changes in prescribing behavior, the rise of telehealth, and shifts to non-personal promotion. Registration is free.
Register Here →
What We Are Seeing and Hearing From the Front Lines at the Point of Care
Via OptimizeRx →
While physician office visits are down, the rapid adoption of virtual healthcare means that providers are still utilizing the EHR during a telehealth visit in the same ways they use it during physical visits. What we’re seeing and hearing from the frontline of this pandemic, is an increased need of information for physicians and patients. Physicians still need treatment protocol information for someone on a certain brand and diagnosed with COVID-19.
Read More Here →
DHC EVENTS UPDATES
The DHC Summit schedule is being continuously evaluated with regard to the safety of our attendees and consideration towards doing our part to #slowthespread. For the following DHC Summits, the DHC is working with our Advisory Board, Summit hosts, and DHC Health Scholars to provide dynamic engagement and learning opportunities.
Midwest Summit is Now May Virtual Summit Series
NEW FORMAT: Three 50 minute sessions over three days, featuring a mix of thought leader presentations, case studies, research and panels. These sessions will be live streamed and available free to industry members.
NEW DATES, SAME TIMES: May 27, May 28 and May 29 at Noon eastern / 11 central.
SAME REGISTRATION: Sign up only once (if you already registered, you will stay registered!) and receive live streaming information for each day's session. Sign Up Now →
A DHC Webinar
Featuring: Marc Monseau (Founder, Mint Collective) and Zoe Dunn (Founder, Hale Advisors) and Q&A with Peter Dannenfelser (AVP, Communications and Digital Innovation, Ferring Pharmaceuticals). This 20 minute on-demand webinar will walk viewers through key steps of a crisis-driven change management.
View Webinar →
This set of infographics from DHC and Sermo offer insights on several areas of impact due to COVID-19. Topics on part one include telehealth, office practice, patient concerns, and information most needed from pharma right now. Part two focuses on the complexities of sales rep access and information needs from the perspective of the physician.”